This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Imamichi, T.
Right arrow Articles by Lane, H. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Imamichi, T.
Right arrow Articles by Lane, H. C.

 Previous Article  |  Next Article 

Journal of Virology, April 2001, p. 3988-3992, Vol. 75, No. 8
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.8.3988-3992.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Amino Acid Deletion at Codon 67 and Thr-to-Gly Change at Codon 69 of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confer Novel Drug Resistance Profiles

Tomozumi Imamichi,1,* Michael A. Murphy,1 Hiromi Imamichi,1 and H. Clifford Lane2

Laboratory of Molecular Retrovirology, Clinical Services Program, Science Applications International Corporation---Frederick, National Cancer Institute---Frederick, Frederick,1 and Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda,2 Maryland

Received 26 October 2000/Accepted 19 January 2001

The potential roles of an amino acid deletion at codon 67 (Delta 67) and a Thr-to-Gly change at codon 69 (T69G) in the reverse transcriptase of human immunodeficiency virus (HIV) type 1 in drug sensitivity and relative replication fitness were studied. Our results suggest that the Delta 67 and T69G changes can be categorized as mutations associated with multidrug resistance. The combination of both mutations with an L74I change (Delta 67+T69G/L74I) leads to a novel 3'-azido-3'-deoxythymidine resistance motif and compensates for impaired HIV replication.


* Corresponding author. Mailing address: Laboratory of Molecular Retrovirology, Clinical Services Program, SAIC---Frederick, NCI---Frederick, Building 550, Room 126, P.O. Box B, Frederick, MD 21702-1201. Phone: (301) 846-5450. Fax: (301) 846-6762. E-mail: timamichi{at}nih.gov.


Journal of Virology, April 2001, p. 3988-3992, Vol. 75, No. 8
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.8.3988-3992.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Shahriar, R., Rhee, S.-Y., Liu, T. F., Fessel, W. J., Scarsella, A., Towner, W., Holmes, S. P., Zolopa, A. R., Shafer, R. W. (2009). Nonpolymorphic Human Immunodeficiency Virus Type 1 Protease and Reverse Transcriptase Treatment-Selected Mutations. Antimicrob. Agents Chemother. 53: 4869-4878 [Abstract] [Full Text]  
  • Villena, C., Prado, J. G., Puertas, M. C., Martinez, M. A., Clotet, B., Ruiz, L., Parkin, N. T., Menendez-Arias, L., Martinez-Picado, J. (2007). Relative Fitness and Replication Capacity of a Multinucleoside Analogue-Resistant Clinical Human Immunodeficiency Virus Type 1 Isolate with a Deletion of Codon 69 in the Reverse Transcriptase Coding Region. J. Virol. 81: 4713-4721 [Abstract] [Full Text]  
  • Wirden, M., Roquebert, B., Derache, A., Simon, A., Duvivier, C., Ghosn, J., Dominguez, S., Boutonnet, V., Ait-Arkoub, Z., Katlama, C., Calvez, V., Marcelin, A.-G. (2006). Risk Factors for Selection of the L74I Reverse Transcriptase Mutation in Human Immunodeficiency Virus Type 1-Infected Patients.. Antimicrob. Agents Chemother. 50: 2553-2556 [Abstract] [Full Text]  
  • Winters, M. A., Merigan, T. C. (2005). Insertions in the Human Immunodeficiency Virus Type 1 Protease and Reverse Transcriptase Genes: Clinical Impact and Molecular Mechanisms. Antimicrob. Agents Chemother. 49: 2575-2582 [Full Text]  
  • Boyer, P. L., Imamichi, T., Sarafianos, S. G., Arnold, E., Hughes, S. H. (2004). Effects of the {Delta}67 Complex of Mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase on Nucleoside Analog Excision. J. Virol. 78: 9987-9997 [Abstract] [Full Text]  
  • Shafer, R. W. (2002). Genotypic Testing for Human Immunodeficiency Virus Type 1 Drug Resistance. Clin. Microbiol. Rev. 15: 247-277 [Abstract] [Full Text]